INDIVIDUALIZATION OF PROPRANOLOL THERAPY = INDIVIDUALISATION DU TRAITEMENT PAR LE PROPRANOLOLSHAND DG.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1063-1069; BIBL. 27REF.Article

THERAPEUTIC DRUG MONITORING OF ANTIARRHYTHMIC AGENTSBROWN JE; SHAND DG.1982; CLIN. PHARMACOKINET.; ISSN 0312-5963; AUS; DA. 1982; VOL. 7; NO 2; PP. 125-148; BIBL. 6 P.Article

ESTIMATION OF KINETIC PARAMETERS FROM A TWO-POINT DETERMINATION OF THE DRUG CUMULATION FACTORBJORNSSON TD; SHAND DG.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 26; NO 5; PP. 540-547; BIBL. 18 REF.Article

PROPRANOLOL WITHDRAWAL SYNDROME - WHY.SHAND DG; WOOD AJ.1978; CIRCULATION; USA; DA. 1978; VOL. 58; NO 2; PP. 202-203; BIBL. 24 REF.Article

PLASMA CONCENTRATIONS AND THE TIME-COURSE OF BETA BLOCKADE DUE TO PROPRANOLOL. = CONCENTRATION PLASMATIQUE ET EVOLUTION AVEC LE TEMPS DU BETA -BLOCAGE DU AU PROPRANOLOLMCDEVITT DG; SHAND DG.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 6; PP. 708-713; BIBL. 14 REF.Article

A PHYSIOLOGICAL APPROACH TO HEPATIC DRUG CLEARANCE.WILKINSON GR; SHAND DG.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 4; PP. 377-390; BIBL. 1 P. 1/2Article

PRESYSTEMIC DRUG ELIMINATIONROUTLEDGE PA; SHAND DG.1979; ANNU. REV. PHARMACOL. TOXICOL.; USA; DA. 1979; NO 19; PP. 447-468; BIBL. 121 REF.Article

PROPRANOLOL IN THE TREATMENT OF CARDIOVASCULAR DISEASEWOOD AJJ; SHAND DG.1978; SOUTH. MED. J.; USA; DA. 1978; VOL. 71; NO 5; PP. 591-594; BIBL. 27 REF.Article

REGIONAL HEMODYNAMIC EFFECTS OF BETA-ADRENERGIC BLOCKADE WITH PROPRANOLOL IN THE UNANESTHETIZED PRIMATE = EFFETS HEMODYNAMIQUES REGIONAUX DU BLOCAGE BETA -ADRENERGIQUE PAR LE PROPRANOLOL CHEZ LES PRIMATES NON ANESTHESIESNIES AS; EVANS GH; SHAND DG et al.sdAMER. HEART J.; U.S.A.; DA. 197; VOL. 85; NO 1; PP. 97-102; BIBL. 16 REF.Serial Issue

ALTERED HEPATIC BLOOD FLOW AND DRUG DISPOSITIONNIES AS; SHAND DG; WILKINSON GR et al.1976; CLIN. PHARMACOKINET.; NETHERL.; DA. 1976; VOL. 1; NO 2; PP. 135-155; BIBL. 2 P. 1/2Article

COMPARISON OF INTRAVENOUS AND ORAL VERAPAMIL DOSINGREITER MJ; SHAND DG; PRITCHETT ELC et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 6; PP. 711-720; BIBL. 22 REF.Article

PROPRANOLOL BINDING IN PLASMA DURING CARDIOPULMONARY BYPASSWOOD M; SHAND DG; WOOD AJJ et al.1979; ANESTHESIOLOGY; USA; DA. 1979; VOL. 51; NO 6; PP. 512-516; BIBL. 10 REF.Article

PREDICTION OF HEPATIC EXTRACTION RATIO FROM IN VITRO MEASUREMENT OF INTRINSIC CLEARANCE.RANE A; WILKINSON GR; SHAND DG et al.1977; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1977; VOL. 200; NO 2; PP. 420-424; BIBL. 19 REF.Article

DISPOSITION OF PROPOXYPHENE AND PROPRANOLOL IN CHILDRENWILSON JT; ATWOOD GF; SHAND DG et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 3; PP. 264-270; BIBL. 13 REF.Article

EFFECTS OF ROUTE OF ADMINISTRATION AND BLOOD FLOW ON HEPATIC DRUG ELIMINATION. = EFFETS DE LA VOIE D'ADMINISTRATION ET DU DEBIT SANGUIN SUR L'ELIMINATION HEPATIQUE DES MEDICAMENTSSHAND DG; KORNHAUSER DM; WILKINSON GR et al.1975; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1975; VOL. 195; NO 3; PP. 424-432; BIBL. 14 REF.Article

ADRENERGIC CONTROL OF TENDON JERK REFLEXES IN MAN = LE CONTROLE ADRENERGIQUE DES REFLEXES TENDINEUX CHEZ L'HOMMEPHILLIPS SJ; RICHENS A; SHAND DG et al.1973; BRIT. J. PHARMACOL.; G.B.; DA. 1973; VOL. 47; NO 3; PP. 595-605; BIBL. 21 REF.Serial Issue

THE DISPOSITION OF PROPRANOLOL. II. HEPATIC ELIMINATION IN THE RATSHAND DG; RANGNO RE; EVANS GH et al.1972; PHARMACOLOGY; SWITZ.; DA. 1972; VOL. 8; NO 4-6; PP. 344-352; BIBL. 6 REF.Serial Issue

THE REDUCTION OF LIDOCAINE CLEARANCE BY DEPROPRANOLOL: AN EXAMPLE OF HEMODYNAMIC DRUG INTERACTION = LA REDUCTION DE LA CLEARANCE DE LA LIDOCAINE PAR LE D. L. PROPRANOLOL: UN EXEMPLE D'UNE INTERACTION HEMODYNAMIQUE DES MEDICAMENTSBRANCH RA; SHAND DG; WILKINSON GR et al.1973; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1973; VOL. 184; NO 2; PP. 515-519; BIBL. 12REF.Serial Issue

A STANDARDIZED ISOPROTERENOL SENSITIVITY TEST. THE EFFECTS OF SINUS ARRHYTHMIA, ATROPINE, AND PROPRANOLOL = UN TEST STANDARDISE DE SENSIBILITE A L'ISOPROTERENOL. LES EFFETS DE L'ARYTHMIE SINUSALE, DE L'ATROPINE ET DU PROPRANOLOLCLEAVELAND CR; RANGNO RE; SHAND DG et al.1972; ARCH. INTERN. MED.; U.S.A.; DA. 1972; VOL. 130; NO 1; PP. 47-52; BIBL. 6REF.Serial Issue

ACTIVE UPTAKE OF PROPRANOLOL BY ISOLATED RABBIT ALVEOLAR MACROPHAGES AND ITS INHIBITION BY OTHER BASIC AMINESVESTAL RE; KORNHAUSER DM; SHAND DG et al.1980; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1980; VOL. 214; NO 1; PP. 106-111; BIBL. 32 REF.Article

DISPOSITION OF CARBAMAZEPINE AND ITS 10,11-EPOXIDE METABOLITE IN THE ISOLATED PERFUSED RAT LIVER.RANE A; SHAND DG; WILKINSON GR et al.1977; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1977; VOL. 5; NO 2; PP. 179-184; BIBL. 28 REF.Article

PERFUSION-LIMITED EFFECTS TO PLASMA DRUG BINDING ON HEPATIC DRUG EXTRACTION.SHAND DG; COTHAM RH; WILKINSON GR et al.1976; LIFE SCI.; G.B.; DA. 1976; VOL. 19; NO 1; PP. 125-130; BIBL. 15 REF.Article

THE RELEASE OF GUANETHIDINE AND BETHANIDINE BY SPLENIC NERVE STIMULATION: A QUANTITATIVE EVALUATION SHOWING DISSOCIATION FROM ADRENERGIC BLOCKADE = LA LIBERATION DE GUANETHIDINE ET DE BETHANIDINE PAR LA STIMULATION DU NERF SPLENIQUE: EVALUATION QUANTITATIVE MONTRANT UNE DISSOCIATION DU BLOCAGE ADRENERGIQUESHAND DG; MORGAN DH; OATES JA et al.1973; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1973; VOL. 184; NO 1; PP. 73-80; BIBL. 18 REF.Serial Issue

LOADING-MAINTENANCE REGIMEN FOR MORE RAPID INITIATION OF THE EFFECT OF GUANETHIDINE. = UN PROGRAMME D'ATTAQUE-ENTRETIEN POUR UN DEBUT PLUS RAPIDE DES EFFETS DE LA GUANETHIDINESHAND DG; NIES AS; MCALLISTER RG et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 2; PP. 139-144; BIBL. 8 REF.Article

LIGNOCAINE DISPOSITION IN BLOOD IN EPILEPSYROUTLEDGE PA; STARGEL WW; FINN AL et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 5; PP. 663-666; BIBL. 12 REF.Article